Michael Lay
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 6
-
- Vitamin D Research Studies 2
- Co-authors
- Jill Barton (3 shared papers)Jane Armitage (2 shared papers)Michael Hill (2 shared papers)Robert Clarke (2 shared papers)Jonathan Emberson (2 shared papers)Rijo Kurien (2 shared papers)Joseph Tomson (2 shared papers)Theingi Aung (2 shared papers)
- Journals
- The Lancet (7 papers)Trials (3 papers)American Heart Journal (1 paper)Journal of the American Heart Association (1 paper)Maturitas (1 paper)
- Partner nations
- United KingdomUnited StatesNepal
In The Last Decade
Michael Lay
14 papers receiving 1.8k citations
Michael Lay's Hit Papers
Peers
Comparison fields: 5 of 56
- Infectious Diseases 1000
- Applied Microbiology and Biotechnology 30
- Pulmonary and Respiratory Medicine 208
- Internal Medicine 15
- Obstetrics and Gynecology 20
Countries citing papers authored by Michael Lay
This map shows the geographic impact of Michael Lay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lay more than expected).
Fields of papers citing papers by Michael Lay
This network shows the impact of papers produced by Michael Lay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lay. The network helps show where Michael Lay may publish in the future.
Co-authors
The 20 scholars most cited alongside Michael Lay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 5 | 2021 | 213 | |
| 6 | Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy Hit paper breakdown → | 2021 | 196 |
| 7 | 2023 | 84 | |
| 8 | 2016 | 36 | |
| 9 | 2017 | 30 | |
| 10 | 2015 | 16 | |
| 11 | 2015 | 13 | |
| 12 | 2015 | 5 | |
| 13 | 2016 | 2 | |
| 14 | 2026 | 1 |
About Michael Lay
Michael Lay is a scholar working on Infectious Diseases, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine and Sociology and Political Science, having authored 14 papers that have together received 1.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Vitamin D Research Studies (2 papers), Ethics in Clinical Research (1 paper), Survey Methodology and Nonresponse (1 paper), Cerebrovascular and Carotid Artery Diseases (1 paper) and Lipoproteins and Cardiovascular Health (1 paper). The work is most often cited by research in Infectious Diseases (1000 citations), Applied Microbiology and Biotechnology (30 citations), Pulmonary and Respiratory Medicine (208 citations), Internal Medicine (15 citations) and Obstetrics and Gynecology (20 citations). Michael Lay has collaborated with scholars based in United Kingdom, United States and Nepal. Frequent co-authors include Jill Barton, Jane Armitage, Michael Hill, Robert Clarke, Jonathan Emberson, Rijo Kurien, Joseph Tomson, Theingi Aung, Richard Haynes and Harold Hin. Their work appears in journals such as The Lancet, Trials, American Heart Journal, Journal of the American Heart Association and Maturitas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.